Finch Therapeutics Group, Inc.
FNCH
$13.45
-$0.55-3.93%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | -- | -- |
| Cost of Revenue | -- | -- | 0.00 | -- | 203.00K |
| Gross Profit | -- | -- | 0.00 | -- | -203.00K |
| SG&A Expenses | 6.11M | 5.16M | 4.68M | 3.74M | 8.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.11M | 5.16M | 4.68M | 3.74M | 9.08M |
| Operating Income | -6.11M | -5.16M | -4.68M | -3.74M | -9.08M |
| Income Before Tax | -4.83M | -3.88M | -3.04M | -2.42M | -6.95M |
| Income Tax Expenses | -- | -- | 0.00 | -- | -- |
| Earnings from Continuing Operations | -4.83M | -3.88M | -3.04M | -2.42M | -6.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.83M | -3.88M | -3.04M | -2.42M | -6.95M |
| EBIT | -6.11M | -5.16M | -4.68M | -3.74M | -9.08M |
| EBITDA | -6.07M | -5.12M | -4.64M | -3.68M | -9.02M |
| EPS Basic | -3.01 | -2.41 | -1.89 | -1.51 | -4.33 |
| Normalized Basic EPS | -1.88 | -1.50 | -1.30 | -0.91 | -2.69 |
| EPS Diluted | -3.01 | -2.41 | -1.89 | -1.51 | -4.33 |
| Normalized Diluted EPS | -1.88 | -1.50 | -1.30 | -0.91 | -2.69 |
| Average Basic Shares Outstanding | 1.61M | 1.61M | 1.61M | 1.61M | 1.60M |
| Average Diluted Shares Outstanding | 1.61M | 1.61M | 1.61M | 1.61M | 1.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
